Galderma has claimed that the results from its Angel study look promising.
The multi-centre, prospective, non-interventional observational study, carried out in France, Germany, Spain and the UK, assessed patient satisfaction at three weeks and four months post treatment of glabellar lines with BoNT-A (s.U).
According to Galderma, the results demonstrated a high level of satisfaction after the treatment, with 94.7% and 89.6% of subjects being “satisfied” or “very satisfied” with the aesthetic outcome at week three and month four, respectively.
Major reasons for satisfaction included the positive aesthetic outcome, a natural appearance, a rested look and the comfort of injection.
Final publication date for the study is expected to be late 2014.